BN Business News
Add your company to Business Communicator →

Market regulation · 16/12/2011

Valeant Pharmaceuticals International, Inc. Reaches Settlement Agreement with Federal Regulators

Valeant Pharmaceuticals International, Inc. has agreed to settle allegations of violating federal law by engaging in unfair or deceptive business practices, as outlined in a consent order attached to a draft complaint.

Original source language: Federal Register — Federal Trade CommissionOpen original release →

Explore insights